Nuvation Bio Inc.

NYSE: NUVB · Real-Time Price · USD
2.75
-0.01 (-0.36%)
At close: Aug 15, 2025, 3:59 PM
2.71
-1.28%
After-hours: Aug 15, 2025, 04:10 PM EDT

Nuvation Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
7.87M n/a n/a n/a
Cost of Revenue
7.08M n/a n/a n/a
Gross Profit
795K -222K -484K -368K
Operating Income
-592.63M -99.82M -119.73M -93.32M
Interest Income
27.06M 24.61M 7.45M 2.96M
Pretax Income
-567.94M -75.8M -104.2M -86.85M
Net Income
-567.94M -75.8M -104.2M -86.85M
Selling & General & Admin
69.23M 28.53M 31.92M 24.28M
Research & Development
99.12M 71.29M 87.81M 69.04M
Other Expenses
425.07M n/a -872K -644K
Operating Expenses
586.34M 99.82M 119.73M 93.32M
Interest Expense
341K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
593.42M 99.82M 119.73M 93.32M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
268.77M 218.88M 216.72M 197.89M
Shares Outstanding (Diluted)
268.77M 218.88M 216.72M 197.89M
EPS (Basic)
-2.11 -0.35 -0.48 -0.44
EPS (Diluted)
-2.11 -0.35 -0.48 -0.44
EBITDA
-566.91M -99.6M -119.53M -89.35M
EBIT
-567.6M -99.82M -119.73M -89.53M
Depreciation & Amortization
683K 222K 484K 368K